The results of an early trial in 31 brain cancer patients finds immune activity boosted in the tumor, and possibly longer survival.

Researchers use 3-D printing technology to construct a brain cancer model that accurately recapitulated in vivo biology and predicted patient drug responses.

Turning to molecular genetics, the Baylor pediatric neurologist and geneticist works to discover the biological basis for the rare neurological diseases she sees in her patients.

The discovery suggests that the immune checkpoint can operate at a further distance from tumor cells than previously believed.

Researchers deliver cancer-fighting drugs to a patient’s brain via the bloodstream, penetrating the blood-brain barrier for the first time.

Tumor cells rapidly divide by usurping a metabolic trick from normal cell development.

Fully developed neurons can revert to stem cell-like states and give rise to brain tumors.

A traditional dentist’s checkup may give patients more than just clean teeth.